Literature DB >> 34114651

Success at Scale: Outcomes of Community-Based Neurodevelopment Intervention (CASITA) for Children Ages 6-20 months With Risk of Delay in Lima, Peru.

Ann C Miller1, Nancy Rumaldo2, Guadalupe Soplapuco2, Alicia Condeso2, Betsy Kammerer3, Shannon Lundy4, Fabiola Faiffer2, Andy Montañez2, Karen Ramos2, Naysha Rojas2, Carmen Contreras2, Maribel Muñoz2, Hilda Valdivia2, Daojing Vilca2, Nandy Córdova5, Patricia Hilario5, Martha Vibbert6,7, Leonid Lecca2, Sonya Shin1,8.   

Abstract

This study is a randomized controlled trial of a 12-week community-based group parenting intervention ("CASITA") in Lima, Peru. CASITA improved neurodevelopment in a pilot study of 60 Peruvian children and subsequently scaled to 3,000 households throughout the district. The objective of this study was to assess intervention effectiveness when implemented at scale. A total of 347 children ages 6-20 months (52.7% male, 100% identified as "mestizo") at risk for developmental difficulties were randomized to immediate or delayed CASITA. At 3 months after enrollment, the immediate arm showed significantly higher overall development, based on the Extended Ages and Stages Questionnaire and Home Observation for Measurement of the Environment scores (Cohen's ds = .36 and .31, respectively). Programs demonstrably effective at scale could help address children's development risks worldwide.
© 2021 The Authors. Child Development © 2021 Society for Research in Child Development.

Entities:  

Mesh:

Year:  2021        PMID: 34114651     DOI: 10.1111/cdev.13602

Source DB:  PubMed          Journal:  Child Dev        ISSN: 0009-3920


  1 in total

1.  Integrating an early child development intervention into an existing primary healthcare platform in rural Lesotho: a prospective case-control study.

Authors:  Melino Ndayizigiye; Ryan McBain; Collin Whelley; Rorisang Lerotholi; Joalane Mabathoana; Merida Carmona; Joe Curtain; Ermyas Birru; Sara Stulac; Ann C Miller; Sonya Shin; Nancy Rumaldo; Joia Mukherjee; Adrianne Katrina Nelson
Journal:  BMJ Open       Date:  2022-02-04       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.